Besides protecting against bone loss and beneficially affecting cholesterol metabolism (Silverman et al, 2012; Stevenson et al, 2015), here we provide evidence in controlling the growth of adenomatous lesions, where mutations in APC form the initial oncogenic insult in 80% of all metastatic colon cancers. The gene discussed is APC; the disease is malignant colon neoplasm.